Table:
begin	end	state
1	25	cytoplasmic
26	44	transmembrane
45	63	non-cytoplasmic
64	83	transmembrane
84	93	cytoplasmic
94	114	transmembrane
115	119	non-cytoplasmic
120	139	transmembrane
140	158	cytoplasmic
159	183	transmembrane
184	189	non-cytoplasmic
190	208	transmembrane
209	253	cytoplasmic
254	273	transmembrane
274	292	non-cytoplasmic
293	311	transmembrane
312	322	cytoplasmic
323	341	transmembrane
342	351	non-cytoplasmic
352	373	transmembrane
374	382	cytoplasmic
383	404	transmembrane
405	414	non-cytoplasmic
415	435	transmembrane
436	449	cytoplasmic

Input:
>Pf1N1B4_2220 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_2220
MFAFFRPAAHQAPLPEEKIDSTYRRLRWQIFAGIFIGYAGYYLLRKNFTLAFPDLIAQGY
TKGQLGVAMSAIAIAYGLSKFLMGIVSDRSNPRYFLPFGLIVSAGVMFVFGFAPWATSSV
TMMFILLFINGWAQGMGWPPSGRTMVHWWSQKERGGVVSVWNTAHNVGGGLIGPLAILGM
GWFNDWHSKFYVPAAVALLVAVFAFIVMRDTPQSTGLPPIEKYKNDYPEGYDASHEEEFS
AKDIFVKYVLRNKMLWFIALANVFVYLLRYGILDWAPTYLKEVKHFDFDKTSWAYFLYEW
AGIPGTLLCGWMSDKIFRGNRGLTGMVFMALVTVATIVYWLNPPGNPMVDMISLFAIGFL
IYGPVMLVGLQALELVPKKAAGTAAGFTGLFGYLGGSVAASALMGYTVDYFGWDGGFILL
VVACLLAMAFLAPTLGHKNVASQSREAIA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server